Smart scan guides new drug combo in lymphoma trial
NCT ID NCT07209059
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 30 times
Summary
This study tests a new treatment for advanced Hodgkin lymphoma that combines the immunotherapy drug nivolumab with chemotherapy. Doctors use PET scans during treatment to see how well it's working and adjust therapy accordingly. The goal is to improve outcomes while reducing side effects. The study involves 30 adults aged 18-60 with newly diagnosed, advanced disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Medical Research Center for Hematology
RECRUITINGMoscow, 125167, Russia
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.